Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli. 2013

Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain. jesusrb@us.es

Two hundred twelve patients with colonization/infection due to amoxicillin-clavulanate (AMC)-resistant Escherichia coli were studied. OXA-1- and inhibitor-resistant TEM (IRT)-producing strains were associated with urinary tract infections, while OXA-1 producers and chromosomal AmpC hyperproducers were associated with bacteremic infections. AMC resistance in E. coli is a complex phenomenon with heterogeneous clinical implications.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
October 2003, Annales francaises d'anesthesie et de reanimation,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
January 1992, Acta clinica Belgica,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
January 1992, Acta clinica Belgica,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
January 1992, Acta clinica Belgica,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
March 1988, Lancet (London, England),
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
February 1988, Lancet (London, England),
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
May 2009, The Netherlands journal of medicine,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
January 2002, Microbial drug resistance (Larchmont, N.Y.),
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
August 2013, Diagnostic microbiology and infectious disease,
Jesús Rodríguez-Baño, and Jesús Oteo, and Adriana Ortega, and Macarena Villar, and M Carmen Conejo, and Germán Bou, and Maitane Aranzamendi-Zaldumbide, and Emilia Cercenado, and Mercè Gurguí, and Luis Martínez-Martínez, and María Merino, and Alba Rivera, and Antonio Oliver, and Irene Weber, and Alvaro Pascual, and Rosa M Bartolomé, and Juan José Gónzalez-López, and José Campos
April 1989, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!